SEC Form 4 · accession 0001567619-18-001925
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Lewis
Director
Period of report
Aug 28, 2018
Accepted (ET)
Aug 30, 2018 · 1:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2018 | M | 7,500 | $14.39 | A | 28,660 | D | |
| Common Stock | Aug 28, 2018 | S | 7,300 | $99.11 | D | 21,360 | D | |
| Common Stock | Aug 28, 2018 | S | 200 | $99.12 | D | 21,160 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1 | $14.39 | Aug 28, 2018 | M | 7,500 | D | Nov 12, 2009 | May 11, 2019 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1Reflects the number of options outstanding after the transactions from this specific stock option grant.